NorthCrest Asset Manangement’s Verona Pharma VRNA Stock Holding History

NorthCrest Asset Manangement’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,670	Closed	-$606K	–	853
2025 Q3	$606K	Sell	5,670 -180	-3%	-$18.8K	0.01%	444
2025 Q2	$535K	Sell	5,850 -4,460	-43%	-$330K	0.01%	407
2025 Q1	$655K	Hold	10,310	–	–	0.02%	373
2024 Q4	$479K	Buy	+10,310	New	+$387K	0.01%	407

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

NorthCrest Asset Manangement's VRNA Position: Q4 2025 in Review

NorthCrest Asset Manangement sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 5,670 shares — an estimated $606K sold.

NorthCrest Asset Manangement first reported a position in VRNA in Q4 2024 and held it in 4 quarters. The position peaked at $655K in Q1 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

NorthCrest Asset Manangement reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
NorthCrest Asset Manangement sold 5,670 Verona Pharma shares in Q4 2025, an estimated $606K.
NorthCrest Asset Manangement first reported a position in Verona Pharma in Q4 2024 and held it in 4 quarters.
NorthCrest Asset Manangement's Verona Pharma position peaked at $655K in Q1 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on NorthCrest Asset Manangement's 13F filing for Q4 2025, filed 8 Jan 2026.